Printer Friendly

Retrometabolic drug design and targeting.


Retrometabolic drug design and targeting.

Bodor, Nicholas and Peter Buchwald.

John Wiley & Sons


405 pages




Bodor (emeritus, U. of Florida) and Buchwald (molecular and cellular pharmacology, U. of Miami) describe general drug design and targeting approaches developed during the past 40 years or so that represent systematic methodologies that thoroughly integrate structure-activity and structure metabolism relationships and are intended to design safe, locally active compounds with an improved therapeutic index. They cover mechanisms of drug action, the drug discovery and development process, retrometabolic drug design, soft drugs, and chemical delivery systems.

([c] Book News, Inc., Portland, OR)

COPYRIGHT 2013 Book News, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Reference & Research Book News
Article Type:Book review
Date:Feb 1, 2013
Previous Article:Contemporary nursing knowledge; analysis and evaluation of nursing models and theories, 3d ed. (CD-ROM included).
Next Article:Textbook of uroradiology, 5th ed.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |